BARBARA LEPETRI
Summary
Forward thinking leader with a proven track record in guiding teams and organizations towards success through strategic planning and effective management. Expertise in building cohesive teams and driving innovation to enhance operational efficiency. Recognized for transforming challenges into opportunities, significantly impacting company growth and profitability. Committed to fostering a culture of continuous improvement and achieving ambitious business objectives.
Overview
32
32
years of professional experience
1
1
Certification
Work History
Chief Science Officer, Associate Partner
The Bloc
New York, NY
05.2016 - Current
- Spearheaded global development and implementation of Behavioral Science strategic offerings. These offerings are frequently cited by clients as differentiating, and user-friendly.
- Expanded service offerings by establishing an in-house Medical Communications group.
- Led the design, development, and implementation of medical strategy deliverables that met internal and client business objectives.
- Collaborated with cross-functional teams to define requirements for new products or services.
- Led a medical team tasked with stimulating great thinking across disciplines. Directed the group to tackle client challenges with a level of scientific curiosity that went beyond the obvious, while maintaining scientific rigor.
- My direct client work includes working with both medical affairs and marketing across the brand building process
- Therapeutic areas include: CV/metabolic (acute coronary syndrome, atrial fibrillation, heart failure, resistant hypertension, diabetes, dyslipidemias, MASH), hematology (ITP, hemophilia A), rare diseases (hereditary angioedema, LGS, Dravet syndrome), ophthalmology (AMD, geographic atrophy, dry eye disease), inflammation (eosinophilic esophagitis, IPF/PPF), psychiatry (MDD, schizophrenia, bipolar disorder), oncology (CLL, DLBCL, MCL, UTUC), addiction (AUD, OUD), sleep (both Rx and OTC), anti-viral (COVID mAb), osteoporosis, and pain.
Senior Vice President, Medical Affairs and Strategic Planning
Sudler & Hennessey
New York, NY
03.2008 - 05.2016
- Led the medical group accountable for medical strategic planning from early development through LOE.
- Established key roles and responsibilities for the medical strategy team, including developing new strategic offerings to expand the company's service offerings.
- Directed the publication planning team for an obesity compound, successfully developing over 30 abstracts, more than 25 posters/oral presentations, and over 15 manuscripts. Spearheaded the development of the publication plan, co-led bi-weekly client meetings, orchestrated author calls, and managed a team of PhD writers to ensure high-quality outputs.
- Therapeutic areas include: hypertension, diabetes, rheumatology (RA, PsA), gastroenterology (UC), nephrology (atypical HUS, STEC-HUS), hereditary angioedema, multiple sclerosis, and osteoarthritis.
Senior Medical Director, Team Leader, LIPITOR/CADUET(US Medical)
Pfizer Inc
New York, NY
06.2003 - 01.2008
- Lead and managed the Lipitor medical group responsible for: Clinical trial design and conduct, data interpretation, presentation and publication and sNDA filings, yearly operating plans and LCM planning.
- Notable accomplishments include partnership with AHA leadership to ensure the guideline writing committee was prepared to amend guidelines post-data release, successful negotiation with the FDA resulting in ten new label enhancements to the Lipitor prescribing information, development and execution of original research grant programs, and successful management of a $250 million budget within tight fiscal constraints.
- Implemented new processes for grants in medical education and clinical trial disclosure.
- Designed and developed programs and processes that were adopted organization-wide. These were cited as reasons that top talent was retained during organizational changes.
- Ensured 100% attendance and compliance with SOP training, and compliance-related activities.
Medical Director, Safety and Risk Management
Pfizer Inc
New York, NY
10.2000 - 06.2003
- Led global pharmacovigilance (PV) matrix teams responsible for PV activities for both in-line and in-development products across the CV portfolio.
- Created a single forum with decision-makers for risk management activities, including conflict resolution.
- Developed and executed process improvements of existing pharmacovigilance activities and structures, including the creation of standardized processes for primary safety data collection and reporting.
- Implemented advanced risk management strategies by championing the philosophy of proactive communication with global regulatory agencies, integrating signal detection tools with existing pharmacovigilance systems, and applying evidence-based methods to more accurately characterize the natural event rates of adverse events.
Medical Director, Arrhythmia Disease Management Team
Pfizer, Inc
New York, NY
01.1997 - 09.2000
- Directed global medical operations, providing support for regulatory registration of NDA.
- Designed targeted educational sessions facilitating successful market introductions.
- Served as medical lead providing strategic insights for the business operating plan.
- Formulated and implemented disease area publication strategy.
Associate Medical Director
Pfizer Inc
New York, NY
01.1995 - 01.1997
- Supervised every phase of clinical trial processes including protocol development, regulatory filings and results dissemination.
- Acted as medical advisor to promotional review committee processes.
- Co-directed creation, implementation, and assessment of outpatient heart failure management program.
- Authored content, including a peer reviewed publication and a book chapter focusing on heart failure disease management.
Faculty Cardiology Attending
St. John’s Queens Medical Center
Elmhurst, NY
01.1993 - 01.1995
- Academic appointment providing both clinical care to patients and mentorship to the cardiology fellows.
- Associate Clinical Instructor, Albert Einstein College of Medicine, with responsibilities for training house staff.
- Cardiology Liaison to the Emergency Department, responsible for improving ER-delivered cardiovascular care, co-developed the chest pain triage center.
Education
Cardiology Fellowship -
Winthrop University Hospital
Mineola, NY01.1993
General Internal Medicine Residency -
Winthrop University Hospital
Mineola, NY01.1990
M.D. -
SUNY at StonyBrook, Medical School
StonyBrook, NY01.1987
BS - Biology
SUNY at Albany
Albany, NY01.1983
Skills
- Initiative-Driven Professional
- Strategic Creative Thinking,
- Cross-Functional Team Collaboration
- Effective Communicator
- Experienced Facilitator
- Behavioral Science Integration into Brand Building
Selected Publications
Hey-Hadavi JH, Kuntze E, Luo D, Silverman P, Pittman D, LePetri B. Tolerability of atorvastatin in a population aged > or =65 years: a retrospective pooled analysis of results from fifty randomized clinical trials. Am J Geriatr Pharmacother. 2006 Jun;4(2):112-22.
Mo J, LePetri B. Statin and adverse events: it does not add up. Am J Cardiol. 2003 Feb 1;91(3):383-4; author reply 384.
Riegel B, Carlson B, Kopp Z, LePetri B, Glaser D, Unger A. Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failure. Arch Intern Med. 2002 Mar 25;162(6):705-12
Smith RH, LePetri B, Moisa RB, Studzinski M, Flaster E, Steingart RM. Association of increased left ventricular mass in the absence of electrocardiographic left ventricular hypertrophy with ST depression during exercise. Am J Cardiol. 1995 Nov 1;76(12):973-4.
Book Chapter Author
Improving outcomes in heart failure: an interdisciplinary approach. Moser, Debra K., Riegel, Barbara
Certification
- Internal Medicine
- Cardiology
Timeline
Chief Science Officer, Associate Partner
The Bloc
05.2016 - Current
Senior Vice President, Medical Affairs and Strategic Planning
Sudler & Hennessey
03.2008 - 05.2016
Senior Medical Director, Team Leader, LIPITOR/CADUET(US Medical)
Pfizer Inc
06.2003 - 01.2008
Medical Director, Safety and Risk Management
Pfizer Inc
10.2000 - 06.2003
Medical Director, Arrhythmia Disease Management Team
Pfizer, Inc
01.1997 - 09.2000
Associate Medical Director
Pfizer Inc
01.1995 - 01.1997
Faculty Cardiology Attending
St. John’s Queens Medical Center
01.1993 - 01.1995
- Internal Medicine
- Cardiology
Cardiology Fellowship -
Winthrop University Hospital
General Internal Medicine Residency -
Winthrop University Hospital
M.D. -
SUNY at StonyBrook, Medical School
BS - Biology
SUNY at Albany
Similar Profiles
Erik VervroegenErik Vervroegen
SVP Creative Director at The BlocSVP Creative Director at The Bloc
BRYAN RAMIREZ MANINGOBRYAN RAMIREZ MANINGO
Receptionist Coordinator at SEDA CENTRAL BLOC. HotelReceptionist Coordinator at SEDA CENTRAL BLOC. Hotel
Karen E. RutledgeKaren E. Rutledge
Senior Manager of Customer Experience at BLOC ManufacturingSenior Manager of Customer Experience at BLOC Manufacturing